11-77 Part 6: Baseline Physical Examination Findings Henry R. Black, Deanne Unger, Alfredo Burlando, John C. Wright, Sara L. Pressel, Ralph Allen, Robert H. McDonald, and Hemantha Surath P resented are results of the physical examina- tions performed on the participants random- ized into the Systolic Hypertension in the Elderly Program (SHEP). Included are data on 4,226 of the total cohort of 4,736 (89.1%). Randomized participants not included were examined, but at least one element of the physical examination was not recorded. All centers performed the physical exami- nations in a standardized fashion (see Methods). Data are presented by age (in 5 -year increments), by race (black or white), by systolic blood pressure (SBP) at randomization (by 10-mm Hg intervals), and by whether participants were on medication when initially screened for SHEP. The actual num- bers and percentages or the means and standard deviations are given in each table. In addition to the data presented in detail, other findings not directly pertinent to the cardiovascular system are noted and summarized at the end. Methods Complete physical examinations were performed at baseline visit 1 by the clinicians at each of the 16 centers. All of those examined had provisionally qualified for enrollment in SHEP at the initial screening or after withdrawal of their antihyperten- sive medication. The physical examination was done as part of good medical care as well as to determine the presence or absence of abnormalities related to eligibility for further participation in SHEP. Exclusions based on physical examination included definite evidence of uncontrolled congestive heart failure, tissue necrosis due to peripheral arterial disease, or a carotid bruit in the appropriate anatom- ical site of a definite transient ischemic attack (TLA) by history. The physical examination was done in a well-lighted, draft-free room at a comfortable tem- perature. A firm-mattressed bed or examining table with a pad cover was used. Participants disrobed completely (with the exception of undershorts or panties) and wore gowns for the examination. Partic- ipants were asked not to smoke immediately before or during the examination. For a description of the methods of measurement of blood pressure and pulse rate, see part 5. 1 Weight was measured in pounds on a calibrated beam balance scale. At each baseline visit, partici- pants were weighed without shoes or outer clothing. Weight was recorded to the nearest pound. Once at baseline, height without shoes was measured and rounded to the nearest inch. A standard direct opthalmoscope was used to visu- alize the optic fundi. Criteria for abnormal fundi were arteriolar spasm or venous constriction, or both, arterio- venous nicking, hemorrage, exudate, or papilledema. The neck was examined for carotid pulsations and bruits. Absent or diminished pulsation was recorded. The thyroid was also examined. The chest and lungs were examined with the participant in the sitting position. Recorded abnor- mal findings on auscultation included wheezing and bilateral rales that did not clear with coughing. The point of maximal cardiac impulse (PMI) was determined. Presence was noted of a PMI that was laterally displaced more than 2 cm from the midcla- vicular line. The heart was examined with the bell of the stethoscope while the participant was in the supine position. Presence of a cardiac murmur or third or fourth heart sound was recorded. The abdomen was examined with the participant in the supine position. Abdominal bruits were identified by auscultation with the diaphragm of the stethoscope. Abnormal abdominal pulses, hepatomegaly (liver span more than 10 cm), and abdominal masses were also noted; these were found in fewer than 1% of random- ized participants and are not further reported here. The extremities were evaluated for evidence of absent or diminished pulses. The femoral, popliteal, and posterior tibial arteries were examined. Presence of femoral bruits and pitting ankle edema was also recorded. The neurological examination consisted of assess- ing the presence of abnormalities of gait, heel and toe walking, station, cranial nerves, visual fields, strength, coordination, or reflexes. These abnormal- ities were very unusual and are not detailed here. Results Overall Findings Table 6.1 summarizes the physical examination findings for all randomized participants. Included are by guest on July 12, 2018 http://hyper.ahajournals.org/ Downloaded from
Transcript
11-77
Part 6: Baseline PhysicalExamination Findings
Henry R. Black, Deanne Unger, Alfredo Burlando, John C. Wright, Sara L. Pressel,
Ralph Allen, Robert H. McDonald, and Hemantha Surath
Presented are results of the physical examina-tions performed on the participants random-ized into the Systolic Hypertension in the
Elderly Program (SHEP). Included are data on 4,226of the total cohort of 4,736 (89.1%). Randomizedparticipants not included were examined, but at leastone element of the physical examination was notrecorded. All centers performed the physical exami-nations in a standardized fashion (see Methods).Data are presented by age (in 5 -year increments), byrace (black or white), by systolic blood pressure(SBP) at randomization (by 10-mm Hg intervals),and by whether participants were on medicationwhen initially screened for SHEP. The actual num-bers and percentages or the means and standarddeviations are given in each table. In addition to thedata presented in detail, other findings not directlypertinent to the cardiovascular system are noted andsummarized at the end.
MethodsComplete physical examinations were performed
at baseline visit 1 by the clinicians at each of the 16centers. All of those examined had provisionallyqualified for enrollment in SHEP at the initialscreening or after withdrawal of their antihyperten-sive medication. The physical examination was doneas part of good medical care as well as to determinethe presence or absence of abnormalities related toeligibility for further participation in SHEP.
Exclusions based on physical examination includeddefinite evidence of uncontrolled congestive heartfailure, tissue necrosis due to peripheral arterialdisease, or a carotid bruit in the appropriate anatom-ical site of a definite transient ischemic attack (TLA)by history. The physical examination was done in awell-lighted, draft-free room at a comfortable tem-perature. A firm-mattressed bed or examining tablewith a pad cover was used. Participants disrobedcompletely (with the exception of undershorts orpanties) and wore gowns for the examination. Partic-ipants were asked not to smoke immediately beforeor during the examination.
For a description of the methods of measurementof blood pressure and pulse rate, see part 5.1
Weight was measured in pounds on a calibratedbeam balance scale. At each baseline visit, partici-pants were weighed without shoes or outer clothing.Weight was recorded to the nearest pound. Once atbaseline, height without shoes was measured androunded to the nearest inch.
A standard direct opthalmoscope was used to visu-alize the optic fundi. Criteria for abnormal fundi werearteriolar spasm or venous constriction, or both, arterio-venous nicking, hemorrage, exudate, or papilledema.
The neck was examined for carotid pulsations andbruits. Absent or diminished pulsation was recorded.The thyroid was also examined.
The chest and lungs were examined with theparticipant in the sitting position. Recorded abnor-mal findings on auscultation included wheezing andbilateral rales that did not clear with coughing.
The point of maximal cardiac impulse (PMI) wasdetermined. Presence was noted of a PMI that waslaterally displaced more than 2 cm from the midcla-vicular line. The heart was examined with the bell ofthe stethoscope while the participant was in thesupine position. Presence of a cardiac murmur orthird or fourth heart sound was recorded.
The abdomen was examined with the participant inthe supine position. Abdominal bruits were identifiedby auscultation with the diaphragm of the stethoscope.Abnormal abdominal pulses, hepatomegaly (liver spanmore than 10 cm), and abdominal masses were alsonoted; these were found in fewer than 1% of random-ized participants and are not further reported here.
The extremities were evaluated for evidence ofabsent or diminished pulses. The femoral, popliteal,and posterior tibial arteries were examined. Presenceof femoral bruits and pitting ankle edema was alsorecorded.
The neurological examination consisted of assess-ing the presence of abnormalities of gait, heel andtoe walking, station, cranial nerves, visual fields,strength, coordination, or reflexes. These abnormal-ities were very unusual and are not detailed here.
ResultsOverall Findings
Table 6.1 summarizes the physical examinationfindings for all randomized participants. Included are
by guest on July 12, 2018http://hyper.ahajournals.org/
11-78 Supplement n Hypertension Vol 17, No 3 March 1991
the means and standard deviations for weight, height,and body mass index as well as the numbers andpercentages of the cohort with positive findings forthe other aspects of the physical examination.
Sample Size and Anthropometric MeasurementsSample size. Table 6.2 gives the numbers and
percentages by age, sex, and race of SHEP random-ized participants who had a complete baseline phys-ical examination; stratification is by level of SBP anduse of antihypertensive medication at initial screen-ing. For both men and women, a higher percentage ofwhites were on medication when screened. For bothblacks and whites, women were more likely than mento have been on medication when screened.
Weight. Mean weight was 162.3 lb (Table 6.3).Weight was lower with greater age, and there were noconsistent differences between those who were on andthose who were not on medication at screening. Meanweight also tended to be lower with higher SBP, andblack women tended to be heavier than white women.
Height. Mean height was 64.3 in. (Table 6.4).Slightly smaller stature was recorded with greaterage. There were no clear differences in relation toSBP or between blacks and whites.
Body mass index. Mean body mass index was 27.5kg/m2 (Table 6.5). As expected, similar to lowerweight and age, mean body mass index was alsoinversely related to age. Black women had a highermean body mass index than white women.
Ocular FundiFundi visualized. Overall, it was possible to visual-
ize the ocular fundi of 79% of randomized partici-pants (Table 6.6). Proportion of fundi visualized waslower with age.
Abnormal fundi. Proportion of visualized fundiwith abnormalities was 30% overall (Table 6.7). Itwas greater with age, greater for blacks than forwhites, and slightly greater for those who were onmedication at screening than for those who were not.For those who were not taking medication at screen-ing, those with SBP of 180 mm Hg or more had thehighest proportion of abnormal fundi. For the groupon medication at screening, frequency of abnormalfundi was lowest in the 160-169 mm Hg SBP stratum.
NeckCarotid bruits. Carotid bruits were noted in 7% of
the cohort (Table 6.8). They tended to be moreprevalent in those who were on medication at screen-ing than in those who were not; the opposite was truefor those with SBP of 180 mm Hg or more. Whiteshad carotid bruits more frequently than blacks. Fre-quency of carotid bruits was highest in those 80 yearsold or older, regardless of medication status atscreening, but there was no consistent pattern amongthe other age strata.
Carotid bruits— Unilateral. Unilateral carotid bruitswere present in 4% of the cohort (Table 6.9). Theywere found equally in those who were on and in those
who were not on medication when screened forSHEP. These bruits were more frequent in whitesthan in blacks and in those 80 years old or older.
Bilateral carotid bruits were present in 3.1% of therandomized participants (data not shown). Thosewith the highest level of SBP at randomization weremost likely to have bilateral carotid bruits. There wasno consistent relation with respect to age, race, or sexfor this physical finding.
Any carotid pulses —Absent or diminished. Carotidpulses were absent or diminished in 2% of the cohort(Table 6.10). This finding was noted more frequentlyin those on than in those not on medication atscreening for SHEP. There was no consistent patternbased on race, age, or level of SBP.
Chest and LungsBilateral rales. Rales were present in 2.2% of the
SHEP cohort at randomization (Table 6.11). Theprevalence of rales was lower in blacks than in whitesfor either sex and lower in younger (60-74 years old)than in older (75 years old or older) age groups.There was no consistent correlation with level of SBPor medication status at screening.
Wheezing. Wheezing was noted in 2.2% of thecohort (Table 6.12). There was no consistent patternfor wheezing in relation to age, level of SBP, ormedication use at screening. Prevalence of wheezingwas higher among black men than among the otherthree race-sex groups.
HeartAny murmur. Murmurs were detected in 26% of
SHEP participants (Table 6.13). Frequency wasgreater with older age and level of SBP but was notrelated to medication status at screening. Blackwomen had a considerably higher prevalence ofmurmurs (41.4%) than did the other three race-sexgroups.
PMl more than 2 cm lateral to midclavicular line.PMI was displaced more than 2 cm lateral to themidclavicular line in only 1% of the SHEP cohort(Table 6.14). This finding was more prevalent witholder age and in blacks than in whites. There were noconsistent patterns in relation to level of SBP ormedication status at screening.
Third heart sounds. Third heart sounds were rarelyheard in the SHEP cohort (0.9%) (Table 6.15). Theywere more frequently found in blacks than in whitesand in those on medication at screening. Level ofSBP at randomization did not relate to frequency ofthird heart sounds.
Fourth heart sounds. Fourth heart sounds werenoted in nearly 9% of randomized SHEP participants(Table 6.16). They were slightly more frequent inthose who were on than in those who were not onmedication at screening, except among white men.Black women had a higher prevalence (14.4%) of thisphysical finding than did the three other race-sexgroups. There was no apparent pattern in relation toage or SBP level.
by guest on July 12, 2018http://hyper.ahajournals.org/
Irregular pulse. Any patient with atrial fibrillation atscreening or during qualifying visits was excludedfrom participation in SHEP (Table 6.17). Nonethe-less, an irregular pulse during the physical examina-tion was noted in 5.4% of the SHEP cohort. Theprevalence of this abnormality was progressivelygreater with age but did not correlate with level ofSBP. Blacks, especially women, were more likely tohave irregular pulses. There was no consistent corre-lation between irregular pulse and medication statusat screening. The precise nature of the irregularitiesnoted is not recorded here. More detailed data onarrhythmias detected by electrocardiogram at base-line in SHEP are reported elsewhere.2
Abdominal BruitsAbnormal abdominal bruits were detected in
nearly 3% of randomized SHEP participants (Table6.18). They were less frequent in black men than inthe other three race-sex groups. There was no con-sistent difference in prevalence in relation to medi-cation status at screening, age, or level of SBP.
ExtremitiesPitting ankle edema. Pitting ankle edema was pres-
ent in almost 9% of the cohort (Table 6.19). It wasmore frequent in SHEP participants on antihyper-tensive medication than in those not on medication atscreening. Pitting ankle edema was found more fre-quently with older age. It was less frequent amongblack men than among the other three race-sexgroups, and it was not related to SBP level.
Femoral bruits. Femoral bruits were heard in nearly7% of SHEP participants (Table 6.20). They weremore frequent in white men than in the other threerace-sex groups. Those on medication at screeninghad a greater prevalence of femoral bruits, as did the
group with SBP of 180 mm Hg or more at random-ization. There was no consistent trend with age.
Peripheral pulses—Diminished or absent. Peripheralpulses were diminished or absent in 21% of the ran-domized participants (Table 6.21). This abnormalitywas more prevalent with older age and higher level ofSBP. Those on medication at screening were also morelikely to have diminished or absent peripheral pulses.
Overall Freedom From Abnormalities, IncludingNeurological Abnormalities
Overall, 15.8% of SHEP participants had no ab-normalities on physical examination (Table 6.22).This finding was inversely related to age. The fre-quency varied inversely in relation to level of SBP butwas slightly lower in those on antihypertensive med-ication at screening than in those not on antihyper-tensive medication at screening. The percentage ofparticipants with no abnormalities was similar inblack men (17.1%), white .men (16.7%), and whitewomen (15.9%), but it was lower in black women(10.5%).
In addition to these findings, 5.6% of the SHEPcohort (2.0% of the men and 8.3% of the women)had breast abnormalities, 3.4% had an abnormalthyroid, and 16.8% had some abnormality found inthe examination of head, ears, nose, or throat (de-tailed data not shown).
References1. Labarthe DR, Blaufox MD, Smith WMcF, Lacy CR, Schnaper
H, LaBaw F, Mascioli S, Davey J, Lakatos E: Part 5: Baselineblood pressure and pulse rate measurements. Hypertension1991;17(suppl II):U-62-11-76
2. Kostis JB, Prineas R, Curb JD, Lee M, Berkson D, Raines J,Frishman W, Francis CK, Sheffield T: Part 8: Electrocardio-graphic characteristics. Hypertension 1991;17(suppl II):II-123-II-151
by guest on July 12, 2018http://hyper.ahajournals.org/
11-80 Supplement II Hypertension Vol 17, No 3 March 1991
Table 6.1 Selected Physical Examination CharacteristicsIdentified at Baseline in 4228 Isolated Systolic Hypertensives
Table
Ho . [ 1) characteristic Mean/Mo. (3D/%) [ 2 I
B. Sample sit* and anthropometric measurements
6.2 Sample Site 4,228 100.06.3 Weight in pounds (mean) 162.3 34.06.4 Height in Inches (mean) 64.3 3.96.5 Body mass index (mean) 27.5 5.0C. Ocular fundi
6.6 Fundi visualised 3,346 79.16.7 Abnormal fundi (% abnormal of those 995 29.7
visualised)
D. Neck
6.8 Carotid bruits (%) 297 7.06.9 Carotid bruits - unilateral (%) 169 4.06.10 Any carotid pulses absent or 84 2.0
diminished (%)
E. Chest, lungs
6.11 Bilateral rales (%) 94 2.2
6.12 Wheeling (%) 92 2.2
F. Heart
6.13 Any nurmur (%) 1,099 26.06.14 PHI > 2 cm lateral to HCL (%) 46 1.16.15 Third heart sound (%) 38 0.96.16 Fourth heart sound (%) 370 8.8
I. Overall free from abnormalities - including neurologic abnormalities
6.22 Ho abnormalities noted 6£6 15.8
[1] Table number for indicated characteristic.[2] The parentheses enclose either a standard deviation (SO) ora percent (%). For the characteristics 6-3 to 6-5, the enclosureis a standard deviation; for the characteristics 6-6 to 6-22, theenclosure is a percent.
3 7 1291892
66
21
.8
. 9
. 1
by guest on July 12, 2018http://hyper.ahajournals.org/
Table) 6.2. Huaber and Percentage of Bandoaixed SHBP ParticipantaBaseline Physical Exaaination
Completing tha
Subgroups
Black Hala60-64 yr65-6970-7475-7980+
Black Feaale60-64 yr65-6970-7475-7980+
Whit* Hale60-64 yr65-6970-7475-7980 +
White Feaale60-64 yr65-6970-7475-7980 +
Black MalaBlack FenalaWhit* MalaWhita Fanale
60-64 yr65-6970-7475-7980 +
Total
Black Mala60-64 yr65-6970-7475-7980 +
Black Fanala60-64 yr65-6970-7475-7960+
White Male60-64 yr65-6970-7475-7980 +
White Fenale60-64 yr65-6970-7475-7980+
Black MaleBlack FemaleWhite MaleWhite Female
60-64 yr65-6970-7475-7980 +
Total
160-169
Mads
281141
1923162010
4779953618
7086
1107348
2688
275387
13819623213377
776
—0.20.30.1_
0.40.50.40.50.2
1.11.92.20.90.4
1.72.02.61.71.1
0.62.16.59.2
3.34.65.53.11.8
18.4
No Mads
1926242011
2429352616
15923017610161
136173162139105
100130727715
338458397286193
1,672
0.40.60.60.50.3
0.60.70.80.60.4
3.85.44.22.41.4
3.24.13.83.32.5
2.43.1
17.216.9
8.010.89.46.84.6
39.5
Baseline Systolic
170-179
Meda
33111
61011109
1243452722
2154505721
948
149203
441101079553
409
0.10.1
__
0.20.20.30.20.2
0.31.01.10.60.5
0.51.31.21.30.5
0.21.13.54.8
1.02.62.52.21.3
9.7
BP (mm
160+
Bo Meds Meds No
Rumbar
812738
51212125
4177586139
48751166457
3846
276360
102176193140109
720
Percentage
0.20.30.20.10.2
0.10.30.30.30.1
1.01.81.41.40.9
1.11.82.71.51.3
0.91.16.58.5
2.44.24.63.32.6
17.0
12120
531193
31426159
824423528
63167
137
1743806140
241
_
_
_
0.10.10.30.20.1
0.10.30.60.40.2
0.20.61.00.80.7
0.10.71.63.2
0.41.01.91.40.9
5.7
Hg)
Meds
24545
47
167
12
1534302832
2343484249
2046
139205
4486998198
410
_0.10.10.10.1
0.10.20.40.20.3
0.40.80.70.70.8
0.51.01.11.01.2
0.51.13.34.8
1.02.12.31.92.3
9.7
Medi
(1212
•
;
3:3(313S21
6213(16(714!
9!16420!
Total
No Neds
294236
1 2724
3348634533
215341264
) 190) 132
) 2071 291! 326
165 2459"
4116"49172"
1 211
L 1581 222L 1,1421 1,280
199 484349 722419 689289 507170 400
1,42(
0.10.30.30.;_
0.1
> 2,602
I 0.71 1.01 0.91 0.6
0.6
) 0.80.9 1.1O.i0.!
1 1.5) 1.1
0.5 0.6
1.5 5.1
3!i1.1
z'.l4.13.S2.3
l.C3.!
11. (17.;
4."8.39.S6.14.C
! 6.11 6.21 4.5! 3.1
4.9> 6.91 7.7I 5.8) 5.0
) 3.7> 5.3> 27.0! 30.3
1 11.417.116.312.09.5
33.7 66.3
Total
3555493426
6584
1018455
277477430268181
306455528410306
199389
1,6332,007
6831,0711,108
796570
4,228
0.61.31.20.80.6
1.52.02.42.01.3
6.611.310.26.34.3
7.210.812.59.77.3
4.79.2
38.647.5
16.225.326.218.613.5
100.0
Yr - Age at Baseline Visit 1Meds " On Dedication at screeningNo Meds « Not on medication at screeningPercentages are of total participants.Tha dash (-) indicates a percentage less than 0.05.The brackets ([ ]) indicate a sample siie of less than tan.
by guest on July 12, 2018http://hyper.ahajournals.org/
11-82 Supplement II Hypertension Vol 17, No 3 March 1991
Tabl* 6.3. H t u and Standard Deviation of Weight in Pounda
Subgroups
Black Mala60-64 yr65-6970-7475-7980 +
Black Fenal*60-64 yr65-6970-7475-7980 +
Whit* Mala60-64 yr65-6970-7475-7980 +
Whit* Famal*60-64 yr65-6970-7475-7980 +
Black HaleBlack Famal*White Mai*Whit* Faoala
60-64 yr65-6970-7475-7980+
Total
Black Hal*60-64 yr65-6970-7475-7980 +
Black F*nal*60-64 yr65-6970-7475-7980 +
Whits Hal*60-64 yr65-6970-7475-7980 +
Whit* Female60-64 yr65-6970-7475-7980 +
Black HalsBlack FemaleWhit* Hal*Whit* Famal*
60-64 yr65-6970-7475-7980 +
Total
160-169
Mads
[214.5][179.6]199.6[168.8][177.0]
181.9161.7166.3167.7154.1
194.7187.4177.1168.6158.6
165.4155.7154.5144.7138.0
189.0167.4180.8152.8
178.4170.2166.7155.3145.4
165.6
[ 77.1][ 13.7]
24.2[ 21.7]
*
41.630.624.036 .126.8
29.935.226.225.623.7
41.531 .729 .731.525.9
28.033.631.033.4
40.535.730.432.526.9
35.1
No Mads
184.6184.2180.1171.7148.3
171.6167.2162.9148 .9151.1
184 .4182.7180.6168.2166.1
157.5155.4146.2141.4133.8
176.8161 .2179.2147.8
172.7171.5165.0153.6146.3
164.2
45.636.435.923.026.5
29.223.929.035.523.9
29.430.131.724.727.2
34.033.925.625.821.8
36.229.730.030 .2
34.734.133.529.228 .0
33.9
Basslina Systolic BP (mm Hg)
170-179
M*ds
[167.0][201.3][150.0][210.0][176.0]
[165.9]181.9166.8152.2[147.6]
191.3179.7179.9172.4164.8
163.4156.6164.7144.4137.5
[182.3]163.1177.2153.9
171.7169.1171.1153.9151.3
164.1
No Mads
M*ar
[192.6]169.1[166.4][177.7][140.1]
[161.2]167.9166.4159.3[136.4]
184.3186 .6171.9166 .0158.4
144.9157.6145.5139.5134.3
168.1161 .1174 .7145.1
165.3171.8155.5153.6143.5
158.7
180 +
Mads No H*d[
l
[168.0][170.5][177.0][175.0]
*
[204.8][155.7]162.5[161.8][164.7]
[171.0]179.5182.0164.3[158.0]
[168.6]147.0147.8148.8133.8
[172.7]168.7173 .8146 .3
179.6159.3161.3155.4141.5
157.5
Standard Deviation
[ 17.1][ 90.7]
***
[ 24.9]47.942.930.2
[ 37.8]
32.230.325.920.520.1
28.536.228.829.822.3
[ 50.8]38.626.731.8
30.138.729.930.327.2
33.2
[ 31.9]39.8
[ 17.5][ 21.1][ 25.2]
[ 30.3]40.737.834.1
[ 42.8]
30.932.320.925.620.4
28.032.431.428.124.7
34.137.028.830.4
35.435.831.130.226.4
33.5
*[ 19.1]
*[ 26.9]
*
[ 17.5][ 10.1]
20.8[ 30.6][ 16.7]
[ 28.5]24.228 .321 .1
[ 16.0]
[ 43.1]22.124.528.322.5
[ 15.1]26.925.626 .9
35.726.329.427.623.7
29.2
224.5183.0171.8156.5165.0
145.3159.3148.3172.3152.8
188.2178.1170.4168.1160.4
158.0154.0145.1141.3123.4
174.6154.5171.4142.5
170.2165.0154.6154 .0141.2
155.2
60.156.042.86.4
25.2
21.424.831.553.035.4
34.525.920.825.729.8
48.432.032.127.119.2
39.834.627.832 .9
45.732.331.531.531.0
34.6
i H*ds
[183.0]183.2194.1[176.4][176.5]
181.5166 .8165.4162.4152.9
192.9184.2178 .6169.1161.3
165.3154.7155.6145.5136.6
185.1166.4178.7151.9
177.0168.5166.8154.9146.3
163.8
[ 43.6]40.426.5
[ 24.2][ 0.7]
36.635.729.233.330.2
30.232.826.423.020.7
38.932.128.930.224.0
32.733.929.131.9
37.935.730.230.726.4
33.7
Total
No M*ds
189.6179.8176.3170.1149.0
166.8166.3159.9155.3149.5
184.7183.1177.5167.5162.5
154.6155.8145.8140.9131.5
174.5159.8177.1146.2
170.9170.8160.8153.7144.3
161.5
42.736.833.821.526.3
29.228.531.736.331.0
29.930.228.825.026.1
34.933.228.726.522.4
36.132.329.630.7
36.034.432.929.628.3
34.1
Total
166.4180.6181.0171.4151.2
174.0166.5161 .9158.6150 .9
186.5183.4178.0167.9162 .1
158 .1155.4149 .6142 .7133.2
176.7162.7177.6148.3
172.7170.0163.1154 .1144.9
162.3
42.338.932.721.926.3
33.631.630.736.030.4
30.130.927.924.424.7
36.532 .829 .228.123.0
35.633.129.431 .3
36.734.832.030.127.8
34.0
Yr m Ag* at Basalin* Visit 1H*ds - On medication at screeningNo Meds ™ Not on medication at screeningSample sixes (denominators) are given in Table 6-2.For means, the asterisk (*) indicates zero sample size.For standard deviations, the asterisk (*) indicates a sample size of zero or one.The brackets ([ ]) indicate a sample size of less than ten.
by guest on July 12, 2018http://hyper.ahajournals.org/
Tabla 6.4. Mean and Standard Deviation of Height in Inchis
Subgroups
Black Male60-64 yr65-6970-7475-7980 +
Black Female60-64 yr65-6970-7475-7980+
White Male60-64 yr65-6970-7475-7980 +
White Female60-64 yr65-6970-7475-7980+
Black MaleBlack FenaleWhita MaleWhite Female
60-64 yr65-6970-7475-7980+
Total
Black Male60-64 yr65-6970-7475-7980 +
Black Female60-64 yr65-6970-7475-7980+
Whita Mala60-64 yr65-6970-7475-7980 +
Whit* Female60-64 yr65-6970-7475-7980 +
Black MalaBlack FemaleWhite MaleWhite Female
60-64 yr65-6970-7475-7980 +
Total
160-169
Meds No Meds
[ 66.5)[ 67.6]
68.6I 66.5][ 65.0]
62.462.762.862.662.1
68.268.167.567.464.9
63.262.362.262.560.9
67.762.567.662.3
64.864.964.763.962.0
64 .4
I 2.1]I 3.9]
3.0[ 1.9]
*
1 .53.91.82.61.9
3.33.13.13.23.9
2.32.52.52.82.9
3.12.63.32.6
3.64.13.83.63.4
3.9
67.967.768.167.465.8
63.362.862.761.762.4
67.667.867.266.866.3
62.662.362.061.461.3
67.662.667.362.0
65.365.464.863.763.2
64.7
3.14.02.82.03.0
2.02.82.02.53.0
3.32.82.92.73.2
2.82.92.83.02.2
3.12.43.02.8
3.93.93.83.93.5
3.9
Baseline Systolic BP (mm
170-179
Meds
67.3 ]67.3]66.0]67.0]68.0]
62.6]63.563.363.661.2]
67.067.567.366 .166.3
62.862.162.161.560.3
67.2]62.967.061.8
64.264.564.463.163.1
63.9
No
[
[
[[[
[
Meds
Mean
68.3] [67.3 [67.0] [70.0) [65.3]
64.2] [61.6 [62.762.1 [61.6] [
67.4 [68.467.366.765.0 [
62.8 [62.462.161.760.9
67.2 [62.367.262.0
65.165.363.864.162.7
64.3
180 +
Meds No
68.0]66.5]54.0]67.5]
*
62.8)64.0]62.260.7)60.3]
68.0]67.468.266.365.9)
61.1)61 .461.861.060.9
65.0]61.867.361 .3
63.263.763.862.562.0
63.1
Standard Deviation
3.1]1.5]***
4.2]3.72.42.72.1]
3.23.33.12.92.2
1.92.72.32.52.2
1.8]3.13.02.5
3.44.03.63.43 .6
3.7
[
(
[
{
I
3.8]1.6 [2.7]4.41 [4.1)
3.9] [4.1 [2.12.6 [1-7] [
3.5 [2.72.82.42.9 (
2.4 [2.52.92.73.2
3.3 [3.03.02.8
3.84.03.73.73 .7
3.9
*2.1]*
4.9]*
0.8]1.7]2.82.4]0.6]
2.6]2.63.02.62.5]
2.9]1.92.42.62.4
5.9]2.42.82.4
3.63.54.13.63.1
3.7
Hg)
Meds
68.0]68.8]68.4]68.5]65.8]
64.0]59.7]61.062.6]61.8
67.966.466.966.566.3
62.762.661.960.859.7
67.861.566.761.4
64.864.163.663.362.4
63.5
0.0]2.6]3.3]1-9)1.3]
1-8]2.0]2.74.4]3.1
3.53.63.83.42.8
2.82.42.44.32.6
2.43.13.43.2
3.83.73.94.84 .1
4.1
Meds
( 67.2]67.467.3
[ 66.9][ 66.5]
62.563.062.862.461.5
68 .067.867.566.765.7
62.962.162.161.860.8
67.262.567.362.0
64.664.664.563.362 .4
64.0
[ 2.2]3.24.9
[ 2.5][ 2.1)
2.33.72.32.71.9
3.23 .13.13.03.0
2.32.52.42.72.6
3.42.73.12.6
3.64.03.83.63 .4
3.8
Total
No Meds
68.067.767.967.965.6
63.562.062.261.962.1
67.667.867.266.865.9
62.662.462.061.460.8
67.562.367.261.9
65.265.264.363.862.9
64.4
3.23.32.82.33.1
2.33.22.32.82.8
3.42.93.02.73.0
2.72.72.83.22.7
3.12.73.02.9
3.93.93.84.03.7
4.0
Total
67.967.667.867.665.7
63.062.462.462.261.8
67.767.867.366.865.9
62.762.362.061.560.8
67.562.467.361.9
65.065.064.463.662.7
64.3
3.03.33.42.43.0
2.33.52.32.82.5
3.32.93.02.83.0
2.62.62.63.02.7
3.12.73.12.8
3.84.03.83.83.6
3.9
Yr a Aga at Baseline Visit 1Meds » On Dedication at screeningNo Meds - Not on medication at screeningSample sizes (denominators) are given in Table 6-2.For means, the asterisk (*) indicates tiro sample size.For standard deviations, the asterisk (*) indicates a sample size of sero or one.The brackets ({ ]) indicate a sample size of lass than ten.
by guest on July 12, 2018http://hyper.ahajournals.org/
11-84 Supplement U Hypertension Vol 17, No 3 March 1991
Tabla 6.5. Mean and Standard Deviation of Body Mass Indiz (kg/a*)
Subgroups
Black Hale60-64 yr65-6970-7475-7960 +
Black Fenala60-64 yr65-6970-7475-7980 +
White Hale60-64 yr65-6970-7475-7980 +
White Fenale60-64 yr65-6970-7475-7980+
Black HaleBlack FenaleWhite HaleWhite Faaala
60-64 yr65-6970-7475-7980+
Total
Black Hale60-64 yr65-6970-7475-7980 +
Black Fenale60-64 yr65-6970-7475-7980+
White Hale60-64 yr65-6970-7475-7980 +
White Fenale60-64 yr65-6970-7475-7980 +
Black KaleBlack FenalaWhite HaleWhite Fenale
60-64 yr65-6970-7475-7980 +
Total
160-169
Heds No Heds
[ 34.5][ 27.7]
29.9( 26.7][ 29.4]
32.929.129.630.028 .2
29.428.427.426.126.6
29.028.228.026.026.0
29.130.127.827.6
29.728.428.026.726.5
28.0
[ 14.4][ 2.8]
4.7I 2.5]
*
7.75.74.46.15.4
3.95.03.93.74.9
6.45.65.05.23.8
4.96.14.45.4
6.15.34.55.14.3
5.2
28.128.227.326.523.9
30.130.029.127.627.4
28.327.928.026.426.5
28.328.126.726.425.0
27.129 .027.727.0
28 .428 .227.526.525.6
27.5
6.84.75.23.33.0
5.35.45.07.15.0
4.54.44 .33.43 .6
6.16.04.64.93.9
5.05.64.35.3
5.45.14.64.64.0
4.9
Baseline Systolic BP Ion
170-179
Heds
26.1 ]30.8]24.2]32.8]26.7)
30.1]32.429.326.427.7]
30.027.627.927.726.3
29.228.530.026.826.6
28.3]29.227.728.3
29.328.629.027.126.7
28.2
No
I[[
[
(
Heds
Hean
28.9]26.126.0]25.4]23.1)
27.3]31.129.928.925.0]
28.428.026.726.126.3
25.828.526.525.725.6
26.029.127.126.5
27.228.326.826.225.6
26.9
[[
[
I
[[
[
[
[
[
180 +
Heds No
25.5]27.0]42.6]26.9]
*
36.5]26.8]29.630.8] [31.8]
25.8]27.727.426.225.6]
31.5)27.427.228.025.3
29.3]31 .026.927.3
31.627.527.827.925.8
27.7
Standard Deviation
5.0]12.4]
***
6.2]11.37.85.07.2]
4.93.93.73.52.7
5.26.75.44.94.5
7.3]7.83.75.6
5.26.55.14.54.3
5.4
[
I[
I
[
3.0]5.51.2]1.5]3.6]
2.7]6.97.15.37.2]
4.14.42.83.43.2
4 .86.05.44.84.9
4.26.33.85.4
4.55.44.94.34.4
4.9
I[
[(
[[
I
[
1
I
*1.3]
0.2J*
3.7] [3.1] [4 .44.7] [3.1]
2.5]3.13.12.83.1]
7.0]4.14 .24.73.8
6.6]4.83.04.6
6.53.64.24.43.9
4.5
Hg)
Heds
34.1]27.1]25.6]23.5]26.7]
24.8)31.4]28.030.4]28.1
28.728.526.926.625.6
28.127.626.627.024.4
26.628.627.126.5
28.328.226.927.025.4
27.0
9-1]7.3]5.0]
3i6]
2-5]5.0]5.27.5]6.8
4.94.43.53.24.4
7.65.65.65.54.0
5.45.94.25.6
6.55.24.95.04.6
5.2
Heds
[ 28.8]28.330.5
I 27.7]1 28.1]
32.829.829.529.328.4
29.328.127.526.726.3
29.228.228.326.725.9
28.930.027.627.7
29.828.328.227.126.4
28.0
[ 8.4]5.75.8
[ 2.9][ 1.9]
7.07.55.45.75.9
4.14.53.73.53.6
6.25.85.05.03.9
5.66.44.05.3
5.95.54.64.84.2
5.1
Total
No Heds
28 .727.526.825.924.2
29.030.529.028.427.3
28.428 .027.626.326.2
27.728.126.626.325.0
26.829.027.526.8
28.228.227.226.525.6
27.3
6.15.24.63.13.5
5.05.65.46.75.9
4 .54 .43.93.43.7
6.15.95.04.94.2
4.95.84.15.4
5.35.24.74 .64.3
5.0
Total
28.827.727.826.324.5
30.930.229.228.827.8
28.628.027.626.426.3
28.228.227.326.525.3
27.229.427.527.2
28.628.227.626.725.8
27.5
6.45.35.23.13.5
6.36.55.46.25.9
4.44.43.93.43.7
6.15.95.15.04.2
5.16.14.15.4
5.65.34.74.64.2
5.0
Yr - Aga at Basalina Visit 1Hads •=• On nadication at scraaningNo Hads « Not on medication at screeningSample slits (denominators) are given in Table 6-2.For naans, the asterisk (*) indicates sero sample sixe.For standard deviations, the asterisk (*) indicates a sample size of zero or on*.The brackets ([ ]) indicate a sample size of less than ten.
by guest on July 12, 2018http://hyper.ahajournals.org/
Table 6.6. Busbar and Percentage with Pnndi Visualized
Subgroups
Black Mai*60-64 yr65-6970-7475-7980+
Black Female60-64 yr65-6970-7475-7980+
Whit* Male60-64 yr65-6970-7475-7980+
White Feaale60-64 yr65-6970-7475-7980+
Black MalaBlack FemaleWhite MaleWhite Female
6u—64 yr65-6970-7475-7980+
Total
Black Male60-64 yr65-6970-7475-7980+
Black Female60-64 yr65-6970-7475-7980+
White Male60-64 yr65-6970-7475-7980+
White Female60-64 yr65-6970-7475-7980+
Black MaleBlack FemaleWhite MaleWhite Fenal*
60-64 yr65-6970-7475-7980 +
Total
160-169
Mads
28
1021
151913168
4165712715
5572875423
2371
219291
1131641819947
604
[100.0][100.0]
90.9[ 50.0][100.0]
78.982.681.380.080.0
87.282.374.775.083.3
78.683.779.174.047.9
88.580.779.675.2
81.983.778.074.461.0
77.8
No Mads
151820168
2024302011
1411931408043
12314412710066
77105597560
299379317216128
1,339
78.969.283.380.072.7
83.382.885.776.968.8
88.783.979.579.270.5
90.483.278.471.962.9
77.080.882.178.3
88.582.879.875.566.3
80.1
Basclin* Systolic BP
170-179
Mads
22111
78
1068
1134352015
1846424815
739
115169
3890887539
330
[ 66.7][ 66.7][100.0][100.0][100.0]
[ 87.5]80.090.960.0
[ 88.9]
91.779.177.874.168.2
85.785.284.084.271.4
[ 77.8]81.377.283.3
86.481.882.278.973.6
80.7
Ho M*d«
(mm Hg)
180 +
Mads
Number
610415
39
1092
3969514223
4265924443
2633
224286
901531579673
569
01110
42
1083
31120127
7243329
32753
110
1438645027
193
P*rc*ntag*
[ 75.0]83.3
[ 57.1]33.3]
[ 62.5]
[ 60.0]75.083.375.0
[ 40.0]
95.189.687.968.959.0
87.586.779.368.875.4
68.471.781.279.4
88.286.981.368.667.0
79.0
—[ 50.0][100.0][ 50.0]
*
I 80.0]I 66.7]90.9
[ 88.9][100.0]
[100.0]78.676.980.0
[ 77.8]
[ 87.5]100.078.682.960.7
[ 50.0]87.179.180.3
82.488.480.082.067.5
80.1
Ho Mads
23424
37
1444
1533242220
2036382927
1532
114150
4079805755
311
[100.0][ 75.0)[ 80.0[ 50.0]80.0]
[ 75.0)[100.0]87.5
I 57.1]33.3
100.097.180.078.662.5
87.083.779.269.055.1
75.069.682.073.2
90.989.880.870.456.1
75.9
Neds
4111242
2629333019
551101265937
8014216213155
33137387570
165292333224113
1,127
[ 66.7]84.692.3
[ 57.1][100.0]
81.380.686.876.986.4
88.780.975.975.675.5
80.886.680.279.456.7
80.582.078.878.4
82.983.779.577.566.5
79.0
Total
Ho Mads
2331281917
2640543317
19529521514486
185245257173136
118170935996
429611554369256
2,219
79.373.877.870.470.8
78.883.385.773.351.5
90.786.581.475.865.2
89.484.278.870.664.5
74.776.661.977.8
88.684.680.472.864.0
79.2
Total
2742402319
5269876336
250405341203123
265387419304191
151307
1,3221,566
594903887593369
3,346
77.176.481.667.673.1
80.082.186.175.065.5
90.384.979.375.768.0
86.685.179.474.162.0
75.978.981.078.0
87.084.380.174.564.7
79.1
yr - Aga at Baseline Visit 1Mads - On medication at screeningHo Mads - Hot on abdication at screeningSample siies (denominators) are given in Table 6-2.The dash (-) indicates a percentage less than 0.05.The asterisk (*) indicates a sanple sixe of zero.The brackets ([ ]) indicate a sample size of less than ten.
by guest on July 12, 2018http://hyper.ahajournals.org/
11-86 Supplement H Hypertension Vol 17, No 3 March 1991
Table 6.7. luabti and Percentage with Abnormal Fnndi (% of Visualised)
Subgroups
Black Hale60-64 yr65-6970-7475-7980 +
Black Female60-64 yr65-6970-7475-7980 +
White Hale60-64 yr65-6970-7475-7980 +
White Fenale60-64 yr65-6970-7475-7980 +
Black HaleBlack FemaleWhite HaleWhite Female
60-64 yr65-6970-7475-7980 +
Total
Black Hale60-64 yr65-6970-7475-7980 +
Black Fenale60-64 yr65-6970-7475-7980+
White Hale60-64 yr65-6970-7475-7980 +
White Feaale60-64 yr65-6970-7475-7980 +
Black HaleBlack FemaleWhite HaleWhite Female
60-64 yr65-6970-7475-7980 +
Total
160-169
Heds
03411
668
115
111217115
111325218
9365678
2834544419
179
—[ 37.5]
40.0[ 50.0][100.0]
40.031.661.568.8
[ 62.5]
26.818.523.940.733.3
20.018.128.738.934.8
39.150.725.626.8
24.820.729.844.440.4
29.6
No Heds
57556
77
10158
3238333319
2626322321
2847
155128
7078807654
358
33382531
[ 75
3529337572
2219234144
2118252331
36442622
2320253542
26
.3
.9
.0
.3
.0]
.0
.2
.3
.0
.7
.7
.7
.6
.3
.2
.1
.1
.2
.0
.8
.4
.8
.0
.9
.4
.6
. 2
.2
.2
.7
Baseline Systolic BP
170-179
Heds
11110
33746
4131455
61214207
4234159
1429363018
127
[ 50.0][ 50.0][100.0][100.0]
_
[ 42.9][ 37.5]70.0
[ 66.7)I 75.0)
36.438.240.025.033.3
33.326.133.341.746.7
[ 57.1)59.035.734.9
36.832.240 .940.046.2
38.5
No Meds
(mm Bg)
180 +
Heds
Nunbtr
23102
11631
91812119
818211018
8125975
2040402430
154
00110
21433
15732
09
12138
2131842
315242013
75
Percentage
I 33.3]30.0
[ 25.0]—
[ 40.0]
[ 33.3][ 11.1]
60.0[ 33.3][ 50.0]
23.126.123.526.239.1
19.027.722.822.741.9
30.836.426.326.2
22.226.125.525.041.1
27.1
*—
(100.0][100.0]
*
[ 50.0]I 50.0]40.0
[ 37.5][100.0]
[ 33.3]45.535.025.0
[ 28.6]
—37.536.444.847.1
[ 66.7]48.134.038.2
21.439.537.540.048.1
38.9
No Heds
13301
24823
39566
698
1211
8192946
1225242021
102
[ 50.0][100.0][ 75.0]
[ 25.0]
[ 66.7][ 57.1]57.1
[ 50.0][ 75.0]
20.027.320.827.330.0
30.025.021.141.440.7
53.359.425.430.7
30.031.630.035.138.2
32.8
Heds
14631
1110191814
1630381912
1734515423
1572
115179
4578
1149450
381
[ 25.0]36.450.0
I 75.0][ 50.0]
42.334.557.660.073.7
29.127.330.232.232.4
21.323.931.541.241.8
45.552.629.731.4
27.326.734.242.044.2
33.8
Total
No Meds
813959
1012242012
4465505034
4053614550
4478
243249
102143144120105
614
34.841.932.126.352.9
38.530.044.460.670.6
22.622.023.334 .739.5
21 .621.623.726.036.8
37.345.926.025.0
23.823.426.032.541.0
27.7
Total
917158
10
2122433826
6095886946
5787
1129973
59150358428
147221258214155
995
33.340.537.534.852.6
40.431.949.460.372.2
24.023.525.834.037.4
21.522.526.732.638.2
39.148.927.127.3
24.724.529.136.142.0
29.7
Tr o Age at Baseline Visit 1Meds » On medication at screeningNo Meds o not on medication at screeningSample sices (denominators) are given in Table 6-6.The dash (—) indicates a percentage less than 0.05.The asterisk (*) indicates * sample sis* of zero.The brackets ([ ]) indicate a sanple size of less than ten.
by guest on July 12, 2018http://hyper.ahajournals.org/
Table 6.8. Huabac and Percentage with Carotid Bruits
Baseline Systolic BP (mm Hg)
160-169 170-179 180+
Subgroups Neds No Heds Neds No Heds Heds No Mads Meds
Total
No Heds Total
Black60-65-70-75-80+
Black60-6 5-70-75-80+
White60-6 5-70-75-80 +
White60-65-70-75-80+
Male64 yr697479
Feaale64 yr697479
Male64 yr697479
Fenale64 yr697479
Black MaleBlack FenaleWhite MaleWhite Feaale
60-64 yr65-6970-7475-7980 +
Total
00000
02002
27840
34763
04
2123
51315105
48
01100
02001
115
1575
76869
23
4336
1814241315
84
00000
02110
21857
24532
04
2316
47
1499
Number
11001
00110
45564
2275
11
32
2427
78
131216
00000
00101
01111
04333
024
13
05545
43 56 19
00001
10113
18513
24754
16
1822
412137
11
47
00000
04213
49
17108
51215128
0104852
925342319
110
12102
12224
1618251412
1112221624
6118585
2934503242
12102
16437
2027422420
1624372832
621
133137
3859845561
187 297
Black60-6 5-70-75-80 +
Black60-65-70-75-80 +
White60-65-70-75-80+
White60-6 5-70-75-80 +
Male64 yr697479
Female64 yr697479
Male64 yr697479
Female64 yr697479
Black MaleBlack renal«White MaleWhite Female
60-64 yr65-6970-7475-7980+
Total
Percentage
-
-
8.7
20.0
4.38.98.4
11.1
4.34.76.48.26.3
4.57.65.9
3.66.66.57.56.5
3.84.2
-
6.9
6.3
6.92.28.56.98.2
5.13.54.94.38.6
2.02.35.95.0
5.33.16.04.57.8
-
-
20.09.1
10.0
16.72.3
17.818.531.8
9.57.4
10.05.39.5
8.315.47.9
9.16.4
13.19.5
17.0
[ 12.5)8.3
[ 12.5]
8.38.3
9 .86.58 .69.8
10.3
4.22.76.07.8
19.3
7.94.38.77.5
6.94.56.78.6
14.7
_
*
9.1
[ 33.3]
7.13.86.7
I 11.1]
16.77.18.6
10.7
6.56.09.5
11.66.36.6
12.5
-
[ 20.0]
[ 25.0]
6.3I 14.3]
25.0
6.723.516.73.69.4
8.79.3
14.611.98.2
5.013.012.910.7
9.113 .613.18.6
11 .2
_
-
11.15.32.6
13.6
6.56.6
10.212.816.3
5.17.37.47.38.2
6.09.87.2
4.57.28.18.0
11.2
3.44.82.8
8.3
3.04.23.24.4
12.1
7.45.39.57.49.1
5.34.16.76.5
11 .4
3.85.07.46.6
6.04.77.36.3
10.5
2.93.62.0
7.7
1.57.14.03.6
12.7
7.25.79.89.0
11.0
5.25.37.06.8
10.4
3.05.48.16.8
5.65.57.66.9
10.7
6.2 5.0 10.5 7.8 7.9 11 .5 7.7 6.7 7.0
Yr » Age at Baseline Visit 1Neds • On medication at screeningNo Meds o Not on medication at screeningSample sites (denominators) are given in Table 6-2.The dash (-) indicates a percentage less than 0.05.The asterisk (*) indicates a sample size of zero.The brackets (( ]) indicate a sample size of less than ten.
by guest on July 12, 2018http://hyper.ahajournals.org/
11-88 Supplement n Hypertension Vol 17, No 3 March 1991
Table 6.9. Haaber and Percentage with Carotid Bruits - Unilateral
Subgroups
Black Hale60-64 yr65-6970-7475-7980 +
Black Feaale60-64 yr65-6970-7475-7980 +
White Male60-64 yr65-6970-7475-7980 +
White Fenale60-64 yr65-6970-7475-7980 +
Black HaleBlack FeaaleWhite HaleWhite resale
60-64 yr65-6970-7475-7980+
Total
Black Hale60-64 yr65-6970-7475-7980+
Black Female60-64 yr65-6970-7475-7980+
White Hale60-64 yr65-6970-7475-7980 +
White Fenale60-64 yr65-6970-7475-7980+
Black MaleBlack FenaleWhite HaleWhite Fenale
60-64 yr65-6970-7475-7980 +
Total
160-169
Heds
00000
01001
12620
23351
02
1114
36972
27
—__——
—4.3—
10.0
2 .12.56.35.6—
2.93.52.76.82.1
_2.34 .03.6
2.23.13.95.32.6
3.5
No Meds
01100
10001
63816
46538
22
2426
1110144
15
54
—3.84 .2—_
4.2———
6.3
3.81.34.51.09.8
2.93.53.12.27.6
2.01.53.33.6
3.32.23.51.47.8
3.2
Baseline Syitolic
170-179
Heds
00000
02000
21353
22321
02
1410
45674
26
—____
_20.0
__
16 .72.36.7
18.513.6
9 .53.76.03.54.8
_4.29.44.9
9.14.55.67.47.5
6.4
BP (mm
180+
No Heds Heds No
Nunber
10001
00010
33132
10446
21
1215
53589
30
Percentage
[ 12.5J
__
[ 12.5]
__—
8.3
7.33.91.74.9
00000
00100
00001
01121
0115
01222
7
—__—*
—_
9.1
_
_
__
5.1 I 11.1]
2.1_
3.46.3
10.5
5.32.24.34.2
4.91.72.65.78.3
4.2
_4 .22.45.73.6
_3 .21.53.6
—2.32.53.35.0
2.9
Hg)
Heds
16
614636
42894
475
46666
6
00000
00002
15212
11442
021112
26656
25
—
__
—_—
.7
.7
.7
.7
.6
.3
.3
.3
.3
.5
.1
.3
.9
.9
.5
.8
.1
.2
.1
.1
Heds
00000
03101
33974
46793
05
2629
71217168
60
-
__
_8.32.6
4.5
4.82.25.49.08.2
4.03.73.55.53.1
—
3.05.34.0
3.53.44.15.54.7
4.2
Total
No Heds
11101
10013
1011115
10
67
131116
45
4753
1819251730
109
3.42.42.8-
4.2
3.0__
2.29.1
4.73.24.22.67.6
2.92.44.04.57.6
2.52.34.14.1
3.72.63.63.47.5
3.9
Total
11101
13114
1314201214
1013202019
4107382
2531423338
169
2.91.82.0_
3.8
1.53.61.01.27.3
4.72.94 .74.57.7
3.32.93.84.96.2
2.02.64.54.1
3.72.93.84.16.7
4.0
Yr - Age at Baseline Visit 1Heds - On medication at screeningNo Heds - Not on medication at screeningSample sizes (denominators) are given in Table 6-2.The dash (-) indicates a percentage less than 0.05.The asterisk (*) indicates a sample siie of zero.The brackets ([ ]) indicate a sample sise of les* than ten.
by guest on July 12, 2018http://hyper.ahajournals.org/
Table. 6.10. Busbar and Percentage with Any Carotid Pulses Absent or Diminished
Subgroups
Black Hale60-64 yr65-6970-7475-7980 +
Black Female60-64 yr65-6970-7475-7980 +
White Male60-64 yr65-6970-7475-7980+
White Female60-64 yr65-6970-7475-7980+
Black HaleBlack FemaleWhite HaleWhite Female
60-64 yr65-6970-7475-7980+
Total
Black Hale60-64 yr65-6970-7475-7980 +
Black Fenale60-64 yr65-6970-7475-7980+
White Hale60-64 yr65-6970-7475-7980+
White Female60-64 yr65-6970-7475-7980 +
Black HaleBlack FanaleWhite HaleWhite Female
60-64 yr65-6970-7475-7980+
Total
160-169
Mads
00000
00002
34111
33132
02
1012
67245
24
———•_
____
20.0
6.45.11 .12.85.6
4.33.50.94.14.2
_2.33.63.1
4.33.60.93.06.5
3.1
No Hads
10000
10110
13420
23220
13
109
56750
23
5.3——
_
4.2
2.93.8_
0.61.32.32.0_
1.51.71.21 .4-
1.02.31.41.3
1.51.31.81.7-
1.4
Basaline
170-179
Heds No
10000
01001
20321
10200
1283
41522
14
Systolic BP (ni
Heds
180+
Nads No
Number
00000
00000
12130
001110073
12241
10
00000
00020
00100
11102
0215
11222
8
Percentage
t 33.3]_—
_
_10.0
__
[ 11.11
16.7_6.77.44.5
4.8_4.0_-
[ 11-1]4.25.41.5
9.10.94.72.13.8
3.4
———
_
___
_
2.42.61.74.9_
0.91.61.8
_2.50.8
1.01.11.02.90.9
1.4
-
__•
___
[ 22. 2)
__
3.8
[ 12.5]4.22.4
7.1
_6.51.53.6
5.92.32.53.35.0
3.3
Hg)
Heds
00000
00000
00100
10120
0014
10220
5
——-——
____—
-_3.3
_
4.3_2.14.8-
_0.72.0
2.3
2.02.5-
1.2
Heds
10000
01023
54532
54434
16
1920
119989
46
[ 16.7J——__
_2.8_5.1
13.6
8.12.93.03.84.1
5.12.42.01 .84.1
2.43.63.92.8
5.52.62.12.85.3
3.2
Total
No Heds
10000
10110
25650
3345113
1816
7
alinl38
3 .4—-
_
3.0_
1.62.2_
0.91.52.32.6_
1.41.01.22.00.5
0.61.41.61.3
1.41.11.62.20.3
1.4
Total
20000
11133
791182
87885
29
3736
1817201910
84
5.7
—
_
1.51.21.03.65.5
2.51.92.63.01.1
2.61.51.52.01.6
1.02.32.31.8
2.61.61.82.41.8
2.0
Yr - Age at Baseline Visit 1Heds = On abdication at screeningNo Mads - Not on medication at screeningSample sicti (denominators) are given in Table 6-2.The dash (-) indicates a percentage less than 0.O5.The asterisk (*) indicates a sample siea of zero.The brackets ([ ]) indicate a sample size of lass than tan.
by guest on July 12, 2018http://hyper.ahajournals.org/
11-90 Supplement II Hypertension Vol 17, No 3 March 1991
Table (.11. anabar and Percentage with Bilateral Rales
Subgroups
Black Hal*60-64 yr65-6970-7475-7980 +
Black Female60-64 yr65-6970-7475-7980 +
White Male60-64 yr65-6970-7475-7980 +
White Female60-64 yr65-6970-7475-7980+
Black HaleBlack FemaleWhite MaleWhite Female
60-64 yr65-6970-7475-7980 +
Total
Black Male60-64 yr65-6970-7475-7980+
Black Ftllli60-64 yr65-6970-7475-7980 +
White Hale60-64 yr65-6970-7475-7980+
White Female60-64 yr65-6970-7475-7980 +
Black HaleBlack FemaleWhite MaleWhite Female
60-64 yr65-6970-7475-7980 +
Total
160-169
KedB
00010
00000
03223
21221
10
108
24454
19
——_
I 25.0]
—
___
—3.82.15.6
16.7
2.91.21.82.72.1
3.8_
3.62.1
1.42.01 .73.85.2
2.4
Ho Mads
10010
10001
43301
12333
22
1112
75645
27
5.3__
5.0_
4 .2___
6.3
2.51.31.7_
1.6
0.71.21.92.22.9
2 .01.51.51.7
2.11.11 .51 .42.6
1.6
Baseline
170-179
Meds No
00000
10000
01221
03323
016
11
14544
18
Systolic BP | H D
Meds
Ruaber
00000
00000
11150
12111
0086
23261
14
180 +
Meds No
00000
00000
00010
00011
0012
00021
3
Percantage
————_
I 12.5]
——_
—2-34.47.44.5
—5.66.03.5
14.3
_2.14.05.4
2.33.64.74.27.5
4.4
—————
-—___
2. 41 .31.7S. 2_
2.12.70.91.61.8
_2.91.7
2.01.71.04. 30.9
1.9
———-*
——___
——-
6.7_
—__
2.93.6
_1.51.5
___
3.32.5
1.2
Hg)
Heds
00000
00101
02120
00123
0256
02344
13
—
--—
——
6.3—
8.3
-5.93.37.1—
——2.14.86.1
_4.33.62.9
_2.33.04.94.1
3.2
Neds
00010
10000
04454
24555
11
1721
389
119
40
-—-
[ 14.3]
3.1—_-_
-2.92.46.48.2
2.02.42.53.05.2
2.40.63.52.9
1.52.32.13.85.3
2.8
Total
Bo Hads
10010
10102
56571
24567
24
2424
910111410
54
3.4——3.7—
3.0—
1.6_
6.1
2.31.81 .93.70.8
1.01 .41.52.43.3
1.31.82.11.9
1.91.41.62.82.5
1.9
Total
10020
20102
5109
125
48
101112
35
4145
1218202519
94
2.9—-
5.9—
3.1—
1.0—3.6
1.82.12.14.52.8
1.31.81.92.73.9
1.51.32.52.2
1.81.71.83.13.3
2.2
Yr - Age at Baseline Visit 1Meds m On medication at screeningBo Meds - Not on medication at screeningSample sices (denominators) are given in Table 6-2.The dash (—) indicates a percentage less than 0.05.The asterisk (*) indicates a sanple siie of zero.The brackets ([ ]) indicate a sample size of less than ten.
by guest on July 12, 2018http://hyper.ahajournals.org/
Yr <• Age at Basalin* Vicit 1Neds m on Dedication at screeningNo Mads » Not on medication at screeningSample sites (denominators) »r* given in Table 6-2.The dash (-) indicates a percentage less than 0.05.The asterisk (*) indicates a sample site of zero.The brackets ([ ]) indicate a sample site of less than ten.
by guest on July 12, 2018http://hyper.ahajournals.org/
11-92 Supplement II Hypertension Vol 17, No 3 March 1991
Tabl* 6.13. laabar and P*rc*ntage with Hnriiir
Subgroups
Black Hale60-64 yr65-6970-7475-7980 +
Black Fenal*60-64 yr65-6970-7475-7980 +
Whit* Hal*60-64 yr65-6970-7475-7980 +
White renale60-64 yr65-6970-7475-7960 +
Black HaleBlack FeaaleWhite HaleWhite Feaale
60-64 yr65-6970-7475-7980+
Total
Black Hale60-64 yr65-6970-7475-7980 +
Black Feaale60-64 yr65-6970-7475-7960 +
White Hale60-64 yr65-6970-7475-7980+
White Feaale60-64 yr65-6970-7475-7980+
Black HaleBlack FeaaleWhite HaleWhite renale
60-64 yr65-6970-7475-7980+
Total
160-169
Heds No Heds
02210
77968
72020102
1018221614
5375980
2447533324
181
—I 25.0]
16.2[ 25.0]
36.830.456.330.080.0
14.925.321.127.811.1
14.320.920.021.929.2
19.242.021.520.7
17.424.022.824.831.2
23.3
32486
7101394
3142452220
2034343638
2343
160162
6188967568
386
15.87.7
16.740.054.5
29.234.537.134.625.0
19.518.325.621.832.8
14.719.721.025.936.2
23.033.122.022.7
18.019.224.226.235.2
23.2
Baseline Systolic BP (la
170-179
Heds
00010
36845
21211126
31616227
1264364
834353918
134
——_
[100.0]_
[ 37.5]60.072.740.0
[ 55.6]
16.727.924.444.427.3
14.329.632.038.633.3
[ 11.1]54.226.931.5
16.230.932.741.134.0
32.8
No Heds
180+
Heds Ho
Hunber
46204
14364
714121912
517311918
16186490
1741484436
186
11020
31713
02553
267
1613
4151544
610192419
78
Percentage
[ 50.0]50.0
[ 28.6]
[ 50.0]
I 20.0]33.325.050.0
[ 80.0]
17.118.220.731.130.8
10.422.726.729.731.6
42.139.123.225.0
16.723.324.931.434.9
26.1
[100.0] [50.0 [
-[100.0] [
* r
1 60.0] [[ 33.3] [63.6
[ 11.1] [[100.0]
—14.319.233.3
[ 33.3]
[ 25.0]25.016.745.746.4
[ 66.7]48.422.432.1
35.323.323.839.347.5
32.4
Hg)
Heds Heds
12412
13729
18
114
11
315131319
10223563
628352041
130
50.050.080.025.040.0
25.042.943.628.675.0
6.723.536.714.334.4
13.034.927.131.038.8
50.047.825.230.7
13.631.835.424.741.8
31.7
13240
1314241116
934362711
1540455434
1078
117168
3891
1079661
393
I 16.7]23.115.4
I 57.1]-
40.638.963.228.272.7
14.525.021.734.622.4
15.224.422.332.735.1
24.446.723.825.9
19.126.125.533.235.9
27.6
Total
No Heds
810109
12
917231717
3964664543
2666786875
4983
259315
84157179139147
706
27.623.827.833.350.0
27.335.436.537.851.5
18.116.825.823.732.6
13.522.723.927.835.5
31.037.422.724.6
17.421.726.027.436.8
25.2
Total
913121312
2231472833
4696
1047254
43106123122109
59161376503
122248266235208
1,099
25.723.624.536.246.2
33.836.946.533.360.0
17.320.524.226.929.8
14.123.323.329.835.4
29.641.423.025.1
17.923.225.829.536.5
26.0
Yr - Ag* at Baseline Visit 1Heds » On abdication at scr**ningHo H*ds — Hot on abdication at screeningSample sizes (denoninators) ar* given in Tabl* 6-2.Th* dash (—) indicates a percentage lass than 0.05.Th* asterisk (*) indicates a sample site of u r o .Th* brackets ([ ] ) indicate a sanple sise of less than ten.
by guest on July 12, 2018http://hyper.ahajournals.org/
Tabl* 6.14. Busbar «nd Percentage) with PHI Ho re Than 2 ca Lateral to RCL
Subgroups
Black Hala60-64 yr65-6970-7475-7980 +
Black Female60-64 yr65-6970-7475-7980 +
Whit* Hal*60-64 yr65-6970-7475-7980+
Whit* Feaal*60-64 yr65-6970-7475-7980+
Black Hal*Black FeaaleWhit* Hal*Whit* Female
60-64 yr65-6970-7475-7980 +
Total
Black Hal*60-64 yr65-6970-7475-7980 +
Black P*mal«60-64 yr65-6970-7475-7980+
Whit* Hala60-64 yr65-6970-7475-7980 +
Whit* F*nal«60-64 yr65-6970-7475-7980 +
Black Hal*Black PanalaWhit* Hal*Whit* Fenale
60-64 yr65-6970-7475-7980 +
Total
160-169
Heds
00000
00100
00000
00130
0104
00230
5
___—
—_
6.3
_
____
——
0.94.1-
1.1_
1.0
-0.92.3-
0.6
Ho Mods
10100
00010
12201
10200
2163
32511
12
5.3_
4.2
—
3.8
0.60.91.1_1.6
0.7_
1.2
-
2.00.80.80.4
0.90.41.30.30.5
0.7
Baseline Systolic
170-179
Hsds
00000
00000
01001
02220
0026
03221
8
__
__
—____
_2.3__
4.5
_3.74.03.5
_1.33.0
_2.71.92.11.9
2.0
BP (an
180 +
No Hads Hads No
Number
00000
00001
01000
00111
0113
01112
5
Percentage
_—
—_
—___
[ 20.0]
_1.3___
_—0.91.61.8
2.20.40.8
_0.60.50.71.8
0.7
00000
00000
00000
00001
0001
00001
1
_{
[*
II
_—________3.6__
0.7
__—_2.5
0.4
Hg)
Hads
01020
11200
00010
00205
3417
12435
15
_25.0]
50.0]_
25.0]14.3]12.5
_
___
3.6
_
4.2
10.2
15.08.70.73.4
2.32.34.03.75.1
3.7
Hads
00000
00100
01001
02351
012
11
03452
14
——_—_
—_2.6
_
_0.7
_2.0
_1.21.53.01.0
_0.60.41.5
_0.91.01.71.2
1.0
Total
No Hads
11120
11211
13211
10516
568
13
45
1058
32
3.42.42.87.4
3.02.13.22.23.0
0.50.90.80.50.8
0.5_1.50.42.8
3.22.70.71.0
0.80.71.51.02.0
1.1
Total
11120
11311
14212
1286757
1024
48141010
46
2.91.82.05.9
1.51.23.01.21 .8
0.40 .80.50.41.1
0.30.41.51 .52 .3
2.51.80.61.2
0.60.71.31.31.8
1.1
Yr - Age at Baseline Visit 1Heds » On Dedication at screeningNo Heds " Not on medication at screeningSample sires (denominators) are given in Tabl* 6-2.The dash (-) indicates a percentage less than 0.05.The asterisk (•) indicates a sample siie of zero.The bracksts (( ]) indicate a sample size of less than ten.
by guest on July 12, 2018http://hyper.ahajournals.org/
11-94 Supplement II Hypertension Vol 17, No 3 March 1991
Table 6.15. R u b t r and F«rc«nttg* with Third Heart Sound
Subgroups
Black Mala60-64 yr65-6970-7475-7980 +
Black Female60-64 yr65-6970-7475-7980 +
Whit* Hale60-64 yr65-6970-7475-7980 +
White Fanale60-64 yr65-6970-7475-7980 +
Black MaleBlack FemaleWhita MalaWhita Famala
60-64 yr65-6970-7475-79S0 +
Total
Black Mala60-64 yr65-6970-7475-7980 +
Black Female60-64 yr65-6970-7475-7980 +
Whita Male60-64 yr65-6970-7475-7980+
White resale60-64 yr65-6970-7475-7980 +
Black HaleBlack FemaleWhite MaleWhite Feaale
60-64 yr65-6970-7475-7980 +
Total
160-169
Mads
00100
00111
01200
01211
1335
02622
12
__
9.1
_
——
6.35.0
10.0
_1.32.1__
_1.21.81.42.1
3.83.41.11.3
_1.02 .61.52.6
1.5
No Meda
11000
01000
01001
02100
2123
15101
8
5.33.8_——
—3.4•_
t
_0.4——
1.6
—1.20.6—-
2.00.80.30.4
0 .31 .10.3_
0.5
0.5
Baseline Systolic
170-179
Meds
00000
00001
00020
00000
0120
00021
3
——___
_——_
11.1]
_—
7.4_
__——-
_2.11.3-
_2.11.9
0.7
BP (am
180 +
No Meds Meds No
Number
00001
10000
00010
01011
1113
11022
6
Percentage
__
_[ 12.5]
1 20.0]
___
_—_
1.6_
_1.3_
1.61 .8
2.62.20.40.8
1.00.6_
1.41.8
0.8
00000
00000
00010
01100
0012
01110
3
__
_*
_-
__
——_
6.7_
_4.22.4_-
__
1.51.5
_2.31 .31 .6-
1 .2
Hg)
Meds
00000
00001
01000
01021
0114
02022
6
_____
____
8.3
_2.9__
_2.3_
4.82.0
_2.20.72.0
_2.3
2.52.0
1.5
Meds
00100
00112
01230
02311
1467
03753
IB
__
7.7__
__
2.62.69 .1
_0.71.23.8
_1.21.50.61.0
2 .42 .41.21 .0
_0.91.71.71.8
1.3
Total
No Meds
11001
11001
02011
04132
334
10
28145
20
3.42 .4__
4 .2
3.02.1__
3.0
_0.6
0.50.8
_1.40.31.20.9
1.91.40.40.8
0.41.10.10.81.3
0.7
Total
11101
11113
03241
06443
47
1017
211898
38
2.91.82.0
3.8
1.51.21.01.25.5
_0.60.51.50.6
_1.30.81.01.0
2.01.80.60.8
0.31.00.71.11.4
0.9
Yr - Age at Baseline Visit 1Meds - On medication at screeningNo Heds =• Not on medication at screeningSample sites (denominators) are given in Table 6-2.The dash (-) indicates a percentage less than 0.05.The asterisk (*) indicates a sanple size of zero.The brackets ([ )) indicate a sample size of leBS than ten.
by guest on July 12, 2018http://hyper.ahajournals.org/
Table 6.16. Bulitr and Pttctntig* with Fourth Baart Sound
Subgroups
Black Male60-64 yr65-6970-7475-7980+
Black Female60-64 yr65-6970-7475-7980 +
White Male60-64 yr65-6970-7475-7980 +
White Female60-64 yr65-6970-7475-7980+
Black MaleBlack FemaleWhite MaleWhite Female
60-64 yr65-6970-7475-7980+
Total
Black Male60-64 yr65-6970-7475-7980 +
Black Female60-64 yr65-6970-7475-7980 +
White Male60-64 yr65-6970-7475-7980+
White Female60-64 yr65-6970-7475-7980 +
Black MalaBlack FemaleWhite MaleWhite Female
60-64 yr65-6070-7475-7980 +
Total
160-169
Meds
00100
54222
24521
681163
1151434
131619106
64
—
9.1——
26.317.412.510.020.0
4.35.15.35.65.6
8.69.3
10.08.26.3
3.817.05.16.8
9.48.28.27.57.8
8.2
No Meds
20220
13241
20171145
41714118
6115754
2737292114
128
10.5—
6.310.0
_
4.210.35.7
15.46.3
12.67.46.34.08.2
2.99.68.67.97.6
6.08.57.87.6
6.08.17.37.37.3
7.7
Baseline Systolic BP (mm
170-179
Neds
10000
23122
37531
02572
1101916
61211125
46
[ 33.31
_—_
[ 25.0]30.09.1
20.0[ 22.2]
25.016.311.111 .14.5
_3.7
10 .012.39.5
I 1 1 . 1 120.812.87.9
13 .610.910 .312.69 .4
11.2
No Meds
Number
10110
13102
310554
59763
37
2730
102214129
67
180+
Meds No
01100
00110
01211
12563
225
17
14984
26
Percentage
[ 12.5]
[ 14.3] [:[ 33.3]
[ 20.0]25.08.3
I[ 40.0]
7.313.08.68.2
10.3 [
10.4 (12.06.09.45.3
7.9 [15.29.88.3
9.812.57.38.68.3
9.3
—50.0] [L00.0] [
_*
I9 .1
11.1] (
_7.17.76.7
11.11
12.5]8.3
11.917.110.7
33.3J6.57.5
12.4
5.99.311.313.110.0
10.8
Hg)
Meds
01100
11414
14344
33112
2111610
5996
10
39
—25.0]20.0]
—
25.0]14.3]25.014.3]33.3
6.711.810.014.312.5
13.07.02.12.44.1
10.023.911.54.9
11.410.29.17.4
10.2
9.5
Meds
11200
77454
5121263
71221198
4273867
2032393015
136
[ 1 6 - 7 17.7
15.4
_
21 .919.410.512.816.2
6.16.87.27.76.1
7.17.3
10.411.56.2
9.816.27.79.2
10.19.29. J
10.48.8
9.5
Total
No Meds
31430
37757
2431191313
1229221613
1129
10094
4268523933
234
10.32.4
11.111.1
_
9.114 .611.111.121.2
11.29.17.26.89.8
5.810.06.77.36.2
7.013.18.87.3
6.79.47.57.78.3
8.4
Total
42630
1014111011
2943311916
1941433721
1556
138161
62100916948
370
11.43.6
12.26.8_
15.416.710.911.920.0
10.59.07.27.18.8
6.29.06.19.06.8
7.514.48.58.0
9.19.36.28.78.4
8.8
yr - Age at Baseline Visit 1Heds " On medication at screeningNo Meds ° Not on Dedication at screeningSample sites (denominators) are given in Table 6-2.The dash (-) indicates a percentage less than 0.05.The asterisk (*) indicates a sample size of sero.The brackets (1 ]) indicate a sample site of less than ten.
by guest on July 12, 2018http://hyper.ahajournals.org/
11-96 Supplement II Hypertension Vol 17, No 3 March 1991
Table* 6.17. Busbar and Percentage) with Irregular Pulse
Subgroups
Black Hala60-64 yr65-6970-7475-7980 +
Black Female60-64 yr65-6970-7475-7980+
Whlta Hala60-64 yr65-6970-7475-7960 +
White Female60-64 yr65-6970-7475-7980+
Black HalaBlack FaaalaWhite HalaHhita Famala
60-64 yr65-6970-7475-7980+
Total
Black Hala60-64 yr65-6970-7475-7980+
Black Female60-64 yr65-6970-7475-7980 +
White Hala60-64 yr65-6970-7475-7980 +
Whita Female60-64 yr65-6970-7475-7980+
Black HalaBlack FemaleWhita HalaWhite Fanala
60-64 yr65-6970-7475-7980 +
Total
160-169
Hads
00000
13113
23323
42243
09
1315
78679
37
_
—__
5.313.06.35.0
30 .0
4.33.83.25.6
16.7
5.72.31.85.56.3
_
10.24.73.9
5.14.12.65.3
11.7
4 .8
Ro Heda
11120
00244
68
1063
34579
5103328
1013181916
76
5.33.84.2
10.0—
—_5.7
15.425.0
3.83.55.75.94.9
2.22.33.15.08.6
5.07.74.53.9
3.02.84.56.68.3
4.5
Basaline Systolic BP
170-179
Heds
00100
00113
04453
11143
151610
157
109
32
_
[100.0]_—
—_9.1
10 .0( 33.3J
—9.38.918.513.6
4.81 .92.07.0
14.3
I 11.1]10.410.74.9
2.34.56.510.517.0
7.8
No Heda Heds
Number
00011
11100
13266
20563
23
1816
448
1310
39
02000
00010
01301
01052
2158
04363
16
Percentage
_
—[ 33.3][ 12.5]
[ 20.0]8.38.3__
2.43.93.49.8
15.4
4.2_
4 .39 .45.3
5.36.56.54.4
3.92.34.19.39.2
5.4
_[100.0
-_*
_
_[ 11.1
_7.1
11.5_
[ 11.1
_4.2_
14.37.1
[ 33.33.27.55.8
_9.33.89.87.5
6.6
(mm Hg)
180+
Ro Heds
01002
01002
01213
24215
33714
2742
12
27
_] I 25.0]
_[ 40.0]
_[ 14.3)
]16.7
—2.96.73.6
] 9.4
8 .79.34.22.4
10.2
] 15.06.55.06.8
4.58.04.02.5
12.2
6.6
Meds
02100
13236
281077
543
138
3153433
817162321
85
-15.47.7_—
3.18.35.37.7
27.3
3.25.96.09.0
14.3
5.12.41.57.98.2
7.39.06.94.5
4 .04.93.88.0
12.4
6.0
Total
Ro Heds
12133
12346
712141312
78121417
1016SB58
1624303438
142
3.44 .82.811.112.5
3.04.24.88.9
18.2
3.33.55.36.89.1
3.42.73.75.78.1
6.37.25.14.5
3.33.34 .46.79.5
5.1
Total
14233
2557
12
920242019
1212152725
13319291
2441465759
227
2.97.34.18.8
11.5
3.16.05.08.321.8
3.24.25.67.510.5
3.92.62.86.68.1
6.58.05.64.5
3.53.84.27.210.4
5.4
Yr - Age at Baseline Visit 1Heds » On Dedication at screeningRo Heds » Hot on medication at screeningSample siies (denominators) are given in Table 6-2.The dash (-) indicates a percentage IBSB than 0.05.The asterisk (*) indicates a sample siie of zero.The brackets ([ ]) indicate a sample sise of less than ten.
by guest on July 12, 2018http://hyper.ahajournals.org/
Table 6.IS. Busbar and Percentage with Abdominal Bruits
Subgroups
Black Mai*60-64 yr65-6970-7475-7980 +
Black Female60-64 yr65-6970-7475-7980+
Whit* Mai*60-64 yr65-6970-7475-7980+
Whit* r*aal*60-64 yr65-6970-7475-7980 +
Black Hal*Black FemaleWhit* Mai*Whit* Female
60-64 yr65-6970-7475-7980+
Total
Black Mala60-64 yr65-6970-7475-7980 +
Black Famala60-64 yr65-6970-7475-7960+
White Male60-64 yr65-6970-7475-7980 +
White Fenale60-64 yr65-6970-7475-7980+
Black MaleBlack FenaleWhite MaleWhite Female
60-64 yr65-6970-7475-7980+
Total
160-169
Mads
00000
11001
31410
40122
0399
82533
21
—___—
5.34.3__
10.0
6.41.34.22.8_
5.7—
0.92.74.2_
3.43.32.3
5.81.02.22.33.9
2.7
No Mads
00000
00000
63340
44733
00
1621
107
1073
37
-
_——
_____
3.81 .31.74.0_
2.92.34.32.22.9
__
2.22.9
3.01.52.52.41.6
2.2
Baseline Systolic BP (nm
170-179
Heds
00000
01010
00210
11440
023
10
12660
15
—
—_
_10.0
10.0_
__
4.43.7_
4.81.98.07.0-
4.22.04.9
2.31.85.66.3-
3.7
No Mads
Number
10000
00001
12240
11402
1198
33643
19
180 +
Mads No
00000
01001
00020
01200
0223
02221
7
Percentage
I 12.5)
_——
—[
_( 20.0] (
2.42.63.46.6_
2.11.33.4_
3.5
2.62.23.32.2
2.91.73.12.92.8
2.6
—_
t*
[33.3]
_33. 3]
__
13.3
_4.24.8
-
_
6.53.02.2
4.72.53.32.5
2.9
Hg)
Mads
00010
10101
03201
03430
136
10
16742
20
—
_25.0]
_
25.0]
6.3
8.3
_8.86 .7_
3.1
_7.08.37.1
5.06 .54.34.9
2.36.87.14.92.0
4 .9
Meds
00000
13012
31640
52762
071422
96
13114
43
—_
__
3.18.3
2.69.1
4.80.73.65.1_
5.11 .23.53.62.1
_
4.22.93.0
4.51.73.13.82.4
3 .0
Total
No Meds
10010
10102
78781
58
1565
24
3139
141623158
76
3.4__3.7_
3.0
1.6
6.1
3.32.32.74.20.8
2.42.74.62.42.4
1.31.82.73.0
2.92.23.33.02.0
2.7
Total
10010
23114
109
13121
101022127
2114561
2322362612
119
2.9
_2.9—
3.13 .61 .01 .27.3
3.61.93.04.50.6
3.32.24.22.92.3
1.02.82.83.0
3.42.13.23.32 .1
2.8
Yr - Age at Baseline Visit 1Heds = On Dedication at screeningHo Meds » Hot on medication at screeningSample sizes (denominators) are given in Table 6-2.The dash (-) indicates a percentage less than 0.05.The asterisk (*) indicates a sample sise of zero.The brackets ([ ]) indicate a sample size of less than ten.
by guest on July 12, 2018http://hyper.ahajournals.org/
11-98 Supplement II Hypertension Vol 17, No 3 March 1991
Table 6.19. Busbar and Percentage with Pitting Ankla Edeaa
Subgroups
Black Hala60-64 yr65-6970-7475-7980 +
Black Female60-64 yr65-6970-7475-7980+
Whits Hala60-64 yr65-6970-7475-7980+
Hhita Penale60-64 yr65-6970-7475-7980 +
Black HalaBlack FanalaHbita HalaWhita Faaala
60-64 yr65-6970-7475-7980 +
Total
Black Hala60-64 yr65-6970-7475-7980 +
Black Faaala60-64 yr65-6970-7475-7980 +
Whita Hala60-64 yr65-6970-7475-7980+
Whita Fanala60-64 yr65-6970-7475-7980+
Black HalaBlack FanalaWhita HalaWhita Fanala
60-64 yr65-6970-7475-7980+
Total
160-169
Hods
00000
31221
38
1262
66
16117
09
3146
1215301910
86
___—
15.84.3
12.510.010.0
6.410.112.616.711.1
8.67.0
14.515.114.6
10.211.311.9
8.77.7
12.914 .313.0
11.1
Bo Kadi
03011
32203
5151787
51315159
5105257
1333342420
124
_11.3_5.09 .1
12.56.95.7_
18.8
3.16.59.77.9
11.5
3.77.59.3
10.68.6
5.07.77.28.0
3.87.28.68.4
10.4
7.4
Basalina Systolic
170-
Mods
01000
12003
12504
04685
16
1223
29
118
12
42
_i 33.3]
__
I 12.5J20.0
__
I 33.3)
8.34.7
11.1_
18.2
_7.4
12.014.023.8
[ 11.1)12.58.1
11.3
4.58.2
10.38.4
22.6
10.3
-179
No Heds
number
01102
11100
41247
15897
43
1830
68
121316
55
BF (ram
180+
Beds No
Percentage
_8.3
I 14.3]
I 25.0]
[ 20.0]8.38.3__
9.81.33.46.6
17.9 [
2.1 [6.76 .9
14.112.3
10.56.56.58.3
5.94 .56.29.3
14.7
7.6
18
21151322
37127
2017
61615
1714111417
14
00000
00200
03422
33375
02
1121
36997
34
—__—* I-_.2__
_.4.4.3• 2]
• 5]
!l.0.9
_.5.4.3
.6
.0
.3
.8
.5
.1
Hg)
M»ds
00001
00006
00413
12345
168
15
1275
15
30
_-__
20.0]
-__—
50.0
-_
13.33.69.4
4.34.76.39.5
10.2
5.013.05.87.3
2.32.37.16.2
15.3
7.3
Hads
01000
43424
4132188
913252617
1175490
1730503629
162
_7.7__—
12.58.3
10.55.1
18.2
6.59.6
12.710.316.3
9.17.9
12.415.817.5
2.410.211.012.4
8.58.6
11.912.517.1
11.4
Total
No Hads
04114
43309
916231317
720262821
101978
102
2043534251
209
_9.52.83.7
16.7
12.16.34.8_
27.3
4.24.78.76.8
12.9
3.46.98.0
11.410.0
6:38.66.88.0
4.16.07.78.3
12.8
7.5
Total
05114
8672
13
1329442125
1633515438
1136
132192
3773
1037880
371
_9.12.02.9
15.4
12.37.16.92.4
23.6
4.76.1
10.27.8
13.8
5.27.39 .7
13.212.3
5.59.38 .19.6
5.46.89.39.8
14.0
8.8
Yr - Aga at Basalina visit 1Hads - On abdication at screeningNo Hads — Mot on medication at screeningSample sisas (denominators) are given in Table 6-2.The dash (-) indicates a percentage less than 0.05.The asterisk (*) indicates a sample site of zero.The brackets ([ ]) indicate a sample size of less than ten.
by guest on July 12, 2018http://hyper.ahajournals.org/
'Table 6.20 Huaber and Ftrcentagt vith Femoral Bruita
Subgroups
Black Hala60-64 yr65-6970-7475-7980+
Black Feaale60-64 yr65-6970-7475-7980+
Whit* Hale60-64 yr65-6970-7475-7980 +
Whit* Paaale60-64 yr65-6970-7475-7980 +
Black Hal*Black resaleWhit* MalaWhit* Pamal*
60-64 yr65-6970-7475-7980 +
Total
Black Hal*60-64 yr65-6970-7475-7980 +
Black Finalt60-64 yr65-6970-7475-7980 +
Whit* Hale60-64 yr65-6970-7475-7900+
Whit* r*nalo60-64 yr65-6970-7475-7980 +
Black MalaBlack Famal*Whit* Mai*Whit* Female
60-64 yr65-6970-7475-7980 +
Total
160-169
M*ds
00001
14110
57882
44645
17
3023
101515138
61
__——
[100.0]
5.317.46.35.0—
10.68.98.422.211.1
5.74.75.55.5
10.4
3.88.010.95.9
7.27.76.59.810.4
7.9
No Mads
11010
21120
131413112
639
107
36
5335
221923249
97
5.33.8—
5.0—
8.33.42.97.7_
8.26.17.410.93.3
4.41.75.67.26.7
3.04.67.34.9
6.54.15.88.44.7
5.8
Baseline Systolic BP I n
170-179
M.ds
01100
03010
03623
23242
24
1413
210975
33
_[ 33.3][100.0]
—_
30.0_
10.0_
_7.0
13.37.4
13.6
9.55.64.07.09.5
I 22.2)8.39.46.4
4.59.18.47.49.4
8.1
No Meds
Number
21000
00000
67742
12411
30
269
9101153
38
180 +
M*ds Do
00010
00001
03521
01730
11
1111
04
1262
24
Percentage
[ 25.0]8.3
[
_
__
[
14.69.1
12.16.65.1 [
2.12.73.41.61.8
7.9 [
9.42.5
8.65.75.73.62.8
5.3
___
50.0] [*
[
—[
33.3]
_21.419.213.311.1]
_4.2
16.78.6-
16.7J3.2
16.48.0
_9.3
15.09.85.0
10 .0
Hg)
Mads
00010
10111
011511
17421
14
1815
2181053
38
__—
25.0]_
25.0]
6.314.3]8.3
_32.416.73.63.1
4.316.38.34.82.0
5.08.7
12.97.3
4.520.510.16.23.1
9.3
Madi
01111
17121
51319126
68
15117
4125547
1229362615
118
_7.77.7
[ 14.3][ 50.0]
3.119.42.65.14.5
8.19.6
11.415.412.2
6.14.97.46.77.2
9.87.2
11.26.5
6.08.38.69 .08.8
8.3
Total
No Mads
32020
31231
193225165
81217139
7109759
3347443415
173
10.34.8-
7.4—
9.12.13.26.73.0
8.89.49.58.43.8
3.94.15.25.34.3
4.44.58.54.6
6.86.56.46.73.8
6.2
Total
33131
48352
2445442811
1420322416
1122
152106
4576806030
291
8.65.52.08.83.8
6.29.53.06.03.6
8.79.4
10.210.46.1
4.64.46.15.95.2
5.55.79.35.3
6.67.17. 27.55.3
6.9
Yr o Aga at Basalin* Visit 1Mads — On medication at scrasningNo Mads » Not on medication at scraeningSample sires (danoninators) ara givan in Tabla 6-2.The dash (-) indicates a percentage less than 0.05.Th* asterisk (*) indicates a sample siia of zero.The brackets ([ ]) indicate a sample tiie of less than ten.
by guest on July 12, 2018http://hyper.ahajournals.org/
11-100 Supplement II Hypertension Vol 17, No 3 March 1991
Tabla 6.21. Busbar and Percentage with Pariptaaral Pulses Diminished or Absent
Subgroups
Black Hale60-64 yr65-6970-7475-7960 +
Black resale60-64 yr65-6970-7475-7980 +
White Hale60-64 yr65-6970-7475-7980 +
White Female60-64 yr65-6970-7475-7980 +
Black MaleBlack resaleWhite MaleWhite resale
60-64 yr65-6970-7475-7980 +
Total
Black Mala60-64 yr65-6970-7475-7980 +
Black Female60-64 yr65-6970-7475-7960 +
White Hale60-64 yr65-6970-7475-7980 +
White Female60-64 yr65-6970-7475-7980 +
Black HaleBlack FemaleWhite MaleWhite Female
60-64 yr65-6970-7475-7980 +
Total
160-169
Mads No Meds
02111
77453
81530112
1110271517
5266680
2634623223
177
—[ 25.0]
9.1[ 25.0][100.0]
36.830.425.025.030.0
17.019.031 .630.611.1
15.711.624.520.535.4
19.229.524.020.7
16.817.326.724.129.9
22.8
35453
43764
273736249
1726222827
2024
133120
5171696343
297
15.819.216.725.027.3
16.710.320.023.125.0
17.016.120.523.814.8
12.515.013.620.125.7
20.018.518.316.8
15.115.517.422.022.3
17.8
Baseline Systolic BP (ma
170-179
Heds
11100
23424
48993
5148
196
3153352
1226223013
103
[ 33.3]I 33.3][100.0]
_—
[ 25.0]30.036.420.0
[ 44.4]
33.318.620.033.313.6
23.825.916.033.328.6
{ 33.3]31.322.125.6
27.323.620.631.624.5
25.2
No Heds
Nuabar
14204
- 22212
417121512
716219
15
119
6068
1439372533
148
180+
Meds No
01000
02031
04
1163
12
111210
16
2436
19222114
67
Percentage
[ 12.5]33.3 [
[ 28.6]_
[ 50.0]
( 40.0)16.7 [16.78.3 [
[ 40.0) [
9.822.120.724.630.8 [
14.6 [21.318.114.126.3
28.9 [19.621.718.9
13.722.219.217.930.3
20.6
—50.0]_ j_ (* r
_ [66.7] [
—33.3] (33.3]
—28.642 .340.033.3)
12.5]8.3
26.234.335.7
16.7)19.435.826.3
5.920.927.534.435.0
27.8
Hg)
Meds
00332
13339
069
105
41158
15
6193043
520202431
100
—_
60.0]75.0]40.0]
25.0]42.9]18.842.9]75.0
_17.630.035.715.6
17.425.610.419.030.6
40.041.321.621.0
11.422.720.229.631.6
24.4
Meds
14211
9128
108
122750268
1726464633
947
123168
3969
1068350
347
[ 16.7]30.815.4
[ 14.3][ 50.0]
28.133.321 .125.636.4
19.419.930.133.316.3
17.215.922 .827.934.0
22.028.125.123.1
19.619.625.328.729.4
24.3
Total
No Heds
49989
78
121015
3160574926
2853484557
3952
223231
70130126112107
545
13.821.425.029.637.5
21 .216.719.022.245.5
14.417.621.625.819.7
13 .518.214.718.427.0
24.723.419.518.0
14.518.018.322.126.8
19.5
Total
513119
10
1620202023
4387
1077534
4579949190
4899
346399
109199232195157
892
14.323.622.426.538.5
24.623.819.823.841.8
15.518.224.928.018.8
14.717.417.822.229.2
24.125.421.219.9
16.016.620.924.527.5
21.1
Yr - Age at Baseline Visit 1Mads » On abdication at screeningNo Meds - Not on medication at screeningSample sises (denominators) are given in Table 6-2.The dash (—) indicates a percentage less than 0.05.The asterisk (*) indicates a sample sixe of zero.The brackets ([ ]) indicate a sample siie of less than ten.
by guest on July 12, 2018http://hyper.ahajournals.org/
Table 6.22. Number and Percentage with Mo Abnormalities Noted (1)
Subgroups
Black Mala60-64 yr65-6970-7475-7980 +
Black resale60-64 yr65-6970-7475-7980 +
White Mala60-64 yr65-6970-7475-7980 +
White Fanala60-64 yr65-6970-7475-7980+
Black MalaBlack FeaaleWhita MalaWhita Faaala
60-64 yr65-6970-7475-7980 +
Total
Black Mala60-64 yr65-6970-7475-79OUT
Black Feaale60-64 yr65-6970-7475-7980+
Whita Mala60-64 yr65-6970-7475-7980+
Whita Faaala60-64 yr65-6970-7475-7980+
Black MalaBlack FamalaWhita MalaWhita Fanala
60-64 yr65-6970-7475-7980 +
Total
160-169
Mads No Mads
12220
34221
13181732
12221488
7125364
2946351511
136
I 50.0][ 25.0]
18.2[ 50.0]
15.817.412.510.010.0
27.722.817.98.3
11.1
17.125.612.711.016.7
26.913.619.316.5
21.023.515.111.314.3
17.5
76530
65400
27522495
323631238
2115117130
7299643513
283
36.823.120.815.0
25.017.211.4__
17.022.613.68.98.2
23.520.819.116.57.6
21.011.516.118.2
21.321.616.112.26.7
16.9
Basalina Systolic
170-179
Mads
10000
01010
36870
67362
12
2424
101411142
51
[ 33.3]
_-
_10.0
—10.0
_
25.014.017.825.9
_
28.613.06.0
10.59.5
( 11.1]4 .2
16.111.8
22.712.710.314.73.8
12.5
No Mads
Rumbar
13100
30140
129
1883
121619106
58
5063
282839229
126
BP (mm
180 +
Mads Mo
Percentage
[ 12.5]25.0
[ 14.3]
I 60.0]_8.3
33.3 [
29.311.731.013.17.7 I
25.0 [21.316.415.610.5
13.217.418.117.5
27.515.920.215.78.3
17.5
22
72011
3789
11
699
1747
142
8
00000
00020
00231
32440
026
13
32691
21
—__
—-21
_.7.0.1]
.5]
.3
.5
.4-
_.5.0.5
.6
.7
.5
.8
.5
.7
Bg)
Mads
00000
10100
67541
37851
02
2324
10141492
49
——_-
25.0]-
6.3—
40.020.616.714.33.1
13.016.316.711.92.0
4.316.511.7
22.715.914.111.12.0
12.0
Mads
22220
35251
162427133
2131211810
81683
101
4262523814
208
I 33.3]15.415.4
I 28.6]
9.413.95.3
12.84.5
25.817.616.316.76.1
21.218.910.410.910.3
19.59.6
16.913.9
21.117.812.413.18.2
14.6
Total
No Hads
89630
105640
456847219
4759583815
2625
190217
1101411176624
458
27.621.416.711.1
30.310.49.58.9_
20.919.917.811.16.8
22.720.317.815.57.1
16.511.316.617.0
22.719.517.013.06.0
16.3
Total
1011850
1310891
6192743412
6890795625
3441
273318
15220316910438
666
28.620.016.314.7
20.011 .97.9
10.71.8
22.019.317.212.76.6
22.219.815.013.78.1
17.110.516.715.8
22.319.015.313.16.7
15.8
Tr ° Age at Basalina Visit 1Mads - On medication at scraaningBo Mads » Not on abdication at screeningSample sises (denominators) are given in Table 6-2.The dash (-) indicates a percentage less than 0.05.The asterisk (*) indicates a sample sice of u r o .The brackets ([ ]) indicate a sample size of less than ten.[1] Including neurologic abnormalities.
by guest on July 12, 2018http://hyper.ahajournals.org/
is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231Hypertension doi: 10.1161/01.HYP.17.3_Suppl.II77
1991;17:II77Hypertension.
http://hyper.ahajournals.org/content/17/3_Suppl/II77.citationWorld Wide Web at:
The online version of this article, along with updated information and services, is located on the
http://hyper.ahajournals.org//subscriptions/
is online at: Hypertension Information about subscribing to Subscriptions:
http://www.lww.com/reprints Information about reprints can be found online at: Reprints:
document. Permissions and Rights Question and Answer process is available in the
Request Permissions in the middle column of the Web page under Services. Further information about thisOffice. Once the online version of the published article for which permission is being requested is located, click
can be obtained via RightsLink, a service of the Copyright Clearance Center, not the EditorialHypertension Requests for permissions to reproduce figures, tables, or portions of articles originally published inPermissions:
by guest on July 12, 2018http://hyper.ahajournals.org/
![CADTH COMMON DRUG REVIEW CADTH Canadian Drug Expert …€¦ · A baseline assessment using an age-appropriate scale (the Hammersmith Infant Neurological Examination [HINE] Section](https://static.documents.pub/doc/80x56/5f19c08c56a69854d427afe5/cadth-common-drug-review-cadth-canadian-drug-expert-a-baseline-assessment-using.jpg)
